Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment
of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from …

T cells play a critical role in cancer control, but a range of potent immunosuppressive
mechanisms can be upregulated in the tumor microenvironment (TME) to abrogate their …

Mesenchymal stem or stromal cells (MSCs) are pluripotent cells implicated in a broad range
of physiological events, including organogenesis and maintenance of tissue homeostasis as …

Tumor behavior is not entirely determined by tumor cells. Studies have demonstrated that a
variety of non-tumor cells in the tumor microenvironment affect tumor behavior; thus, a new …

The initiation and progression of malignant tumors are supported by their microenvironment:
cancer cells per se cannot explain growth and formation of the primary or metastasis, and a …

Mesenchymal stem cells (MSCs) are multipotent stromal cells which can differentiate into a
variety of cell types including osteoblasts, adipocytes and chondrocytes. They are normally …

In recent years, mesenchymal stem/stromal cells (MSCs) have widely been considered as
therapeutic tools in basic researches and clinical trials. Accumulating evidence supports the …

Liver diseases caused by viral infection, alcohol abuse and metabolic disorders can
progress to end‐stage liver failure, liver cirrhosis and liver cancer, which are a growing …

While a large and growing body of research has demonstrated that mesenchymal
stem/stromal cells (MSCs) play a dual role in tumor growth and inhibition, studies exploring …

Mesenchymal stem cells (MSCs) loaded with oncolytic viruses are presently being
investigated as a new modality of advanced/metastatic tumors treatment and enhancement …